Actein Antagonizes Oral Squamous Cell Carcinoma Proliferation through Activating FoxO1
Conclusions: Our findings demonstrated that actein could be a strong anti-OSCC candidate. Further evaluations of its safety and effectiveness are necessary before it can be considered for clinical use.Pharmacology
Source: Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Cancer & Oncology | Carcinoma | Drugs & Pharmacology | Oral Cancer | Skin Cancer | Squamous Cell Carcinoma | Study